PubMed Health⌕ Search

Biomedical subjects

John Ellul

Publications and source records attributed to John Ellul.

6 recordsLinked to original sources
PubMed2005

The effect of depression on motor function and disease severity of Parkinson's disease.

OBJECTIVES: Approximately 40% of patients with Parkinson's disease (PD) experience symptoms of depression. Our aim was to evaluate the effect of depression on disease severity, motor function and other phenotypic characteristics of PD. PATIENTS AND METHODS: We studied 32 PD patients with major depression (PD-D) according to the DSM-IV criteria and 32 PD patients with no depression (PD-C) matched for gender, age of onset and duration. RESULTS: Major depression in PD patients was associated with increased disease severity, poorer motor function and worse performance in the activities of daily living as measured by UPDRS scores. Furthermore, there was an association of depression with the severity of bradykinesia and axial rigidity. CONCLUSIONS: Depression in PD can have a profound negative impact on a patient's sense of wellbeing and motor functioning. Therefore, PD patients should be routinely and carefully screened for the presence of depression and appropriate management should be considered. Larger studies on the subject are warranted.

Cross-Sectional Studies↗
PubMed2005

Factors associated with drug-induced visual hallucinations in Parkinson's disease.

AIMS: Visual hallucinations are common in medication-treated Parkinson's disease (PD) patients. Although their etiology is unknown several factors seem to be involved in their pathogenesis. The aim of this study was to identify possible risk factors and determine clinical characteristics associated with the development of visual hallucinations in PD. METHODS: 166 consecutive patients fulfilling clinical criteria for PD were studied. During a semi-structured interview, demographic characteristics and clinical variables were recorded. Motor, cognitive and psychiatric status was also assessed. Patients with and without visual hallucinations were compared using non-parametric tests, and logistic regression was applied to significant data. RESULTS: During the month before evaluation 20.4% of our patients experienced visual hallucinations (11.4% benign, 9% malignant). Logistic regression analysis identified three factors independently associated with visual hallucinations: long duration of Parkinson's disease, dementia, and disease severity as measured by the UPDRS total score. CONCLUSIONS: Our findings indicate that apart from well established risk factors such as cognitive impairment and disease duration, disease severity is also important for the development of visual hallucinations in PD. Furthermore, the presence of bradykinesia and instability, the absence of tremor and the severity of rigidity and bradykinesia (limb and axial) may act as cofactors.

Age of Onset↗
PubMed2004

Progressing stroke: towards an internationally agreed definition.

BACKGROUND: The study of early neurological deterioration (progression) in acute stroke has been hampered by a lack of standardisation in the terminology or assessment procedures. An international panel was therefore convened, to agree on robust operational definitions for future studies and to validate them in an observational study involving 10 centres from the European Stroke Database Collaboration. METHODS: Standardised neurological assessments were performed daily for the first 3 days on patients with acute stroke, consecutively admitted within 24 h of onset, using the Scandinavian Stroke Scale (SSS) scoring system. An early deterioration episode (EDE) was defined as a >/=2 SSS-point worsening in either conscious level, arm, leg or eye movement scores, and/or a >/=3 SSS-point worsening in speech score, between consecutive neurological assessments. Stroke progression (SP) was defined as a similar neurological worsening comparing the day 3 assessment with the baseline assessment, or death occurring within 72 h of onset. The ability of SP to predict poor outcome (death or a Barthel ADL score <15/20 at 3 months), independently of initial stroke severity or other prognostic factors, was compared with possible alternative definitions, including one based on the Canadian Stroke Scale. RESULTS: The occurrence of EDEs and SP within the first 3 days of admission could be determined in 563 cases. EDEs occurred in 33% and SP in 26% of cases. Both were strong independent predictors of poor outcome. The prognostic efficiency of the European Progressing Stroke Study (EPSS) definition of SP was better than any of the alternatives examined, and clearly better than a definition based on changes in the total SSS score. CONCLUSIONS: The EPSS definitions of EDEs and SP have good construct and prognostic validity. They can be recommended as a standard for future studies on the aetiology and mechanisms of this common and important phenomenon.

Acute Disease↗